By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Iroko Pharmaceuticals 

Philadelphia  Pennsylvania    U.S.A.
Phone: Fax:



Company News
Iroko Pharmaceuticals Release: New Data Shows That VIVLODEX Reduces Rescue Medication Use In Patients With Osteoarthritis Pain 5/12/2016 7:55:01 AM
Iroko Pharmaceuticals Release: Survey Finds 8 In 10 Americans Experience Different Forms Of Pain But Many Are Unable To Effectively Control It 4/7/2016 8:17:41 AM
Iroko Pharmaceuticals To Present Phase 3 VIVLODEX Efficacy And Safety Data At World Congress Of Osteoarthritis 3/31/2016 9:27:32 AM
Iroko Pharmaceuticals Release: VIVLODEX Now Available In U.S. Pharmacies For The Management Of Osteoarthritis Pain 2/16/2016 9:12:16 AM
Iroko Pharmaceuticals Receives FDA Approval For VIVLODEX - First Low Dose SoluMatrix Meloxicam For Osteoarthritis Pain 10/23/2015 7:36:09 AM
Iroko Pharmaceuticals Announces Eighth International Licensing Agreement For ZORVOLEX 7/15/2015 10:02:36 AM
Iroko Pharmaceuticals Release: TIVORBEX Now Available In U.S. Pharmacies For The Treatment Of Acute Pain 6/29/2015 10:51:18 AM
Iroko Pharmaceuticals Announces First International Launch Of ZORVOLEX 5/14/2015 11:17:11 AM
Iroko Pharmaceuticals Announces Additional International Licensing Agreement For ZORVOLEX 5/6/2015 11:34:46 AM
Iroko Pharmaceuticals Granted New Patent For ZORVOLEX 4/29/2015 11:02:38 AM